Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 30-Dec-22 7:16 PM View:  | Flynn James E 10% Owner | Oncorus, Inc. (ONCR) | 30-Dec-22 | Sale | 138,872 | $0.27 | $37,495.40 | (5%) 2.74M to 2.6M | |
| 30-Dec-22 7:16 PM View: | Flynn James E 10% Owner | Oncorus, Inc. (ONCR) | 29-Dec-22 | Sale | 141,753 | $0.26 | $36,855.80 | (5%) 2.88M to 2.74M | |
| 30-Dec-22 7:16 PM View: | Flynn James E 10% Owner | Oncorus, Inc. (ONCR) | 28-Dec-22 | Sale | 55,610 | $0.25 | $13,902.50 | (2%) 2.93M to 2.88M | |
| 27-Dec-22 6:33 PM View: | Flynn James E 10% Owner | Oncorus, Inc. (ONCR) | 27-Dec-22 | Sale | 65,090 | $0.27 | $17,574.30 | (2%) 3.0M to 2.93M | |
| 27-Dec-22 6:33 PM View: | Flynn James E 10% Owner | Oncorus, Inc. (ONCR) | 22-Dec-22 | Sale | 8,294 | $0.28 | $2,322.32 | (< 1%) 3.01M to 3.0M | |
| 21-Dec-22 7:09 PM View: | Flynn James E 10% Owner | Oncorus, Inc. (ONCR) | 21-Dec-22 | Sale | 13,800 | $0.30 | $4,140.00 | (< 1%) 3.02M to 3.01M | |
| 21-Dec-22 7:09 PM View: | Flynn James E 10% Owner | Oncorus, Inc. (ONCR) | 20-Dec-22 | Sale | 14,740 | $0.31 | $4,569.40 | (< 1%) 3.04M to 3.02M | |
| 21-Dec-22 7:09 PM View: | Flynn James E 10% Owner | Oncorus, Inc. (ONCR) | 19-Dec-22 | Sale | 99,718 | $0.29 | $28,918.20 | (3%) 3.14M to 3.04M | |
| 15-Dec-22 6:50 PM View: | Flynn James E 10% Owner | Oncorus, Inc. (ONCR) | 15-Dec-22 | Sale | 3,089 | $0.39 | $1,204.71 | (< 1%) 3.14M to 3.14M | |
| 15-Dec-22 6:50 PM View: | Flynn James E 10% Owner | Oncorus, Inc. (ONCR) | 14-Dec-22 | Sale | 8,600 | $0.38 | $3,268.00 | (< 1%) 3.15M to 3.14M | |
| 15-Dec-22 6:50 PM View: | Flynn James E 10% Owner | Oncorus, Inc. (ONCR) | 13-Dec-22 | Sale | 2,097 | $0.41 | $859.77 | (< 1%) 3.15M to 3.15M | |
| 25-May-22 4:51 PM View: | Wanstall Rick CFO and Treasurer | Oncorus, Inc. (ONCR) | 25-May-22 | Private Purchase | 3,777 | $1.20 | $4,532.40 | 8% 47.22K to 51.0K | |
| 24-May-22 4:30 PM View: | Wanstall Rick CFO and Treasurer | Oncorus, Inc. (ONCR) | 20-May-22 | Private Purchase | 1,610 | $1.20 | $1,932.00 | 4% 45.61K to 47.22K | |
| 19-May-22 4:15 PM View: | Wanstall Rick CFO and Treasurer | Oncorus, Inc. (ONCR) | 19-May-22 | Purchase | 5,000 | $1.29 | $6,450.00 | 12% 40.61K to 45.61K | |
| 19-May-22 4:15 PM View: | Wanstall Rick CFO and Treasurer | Oncorus, Inc. (ONCR) | 17-May-22 | Private Purchase | 1 | $1.20 | $1.20 | < 1% 40.61K to 40.61K | |
| 16-May-22 10:00 PM View: | Wanstall Rick CFO and Treasurer | Oncorus, Inc. (ONCR) | 16-May-22 | Purchase | 20,620 | $1.18 | $24,331.60 | 103% 19.99K to 40.61K | |
| 16-May-22 10:00 PM View: | Wanstall Rick CFO and Treasurer | Oncorus, Inc. (ONCR) | 13-May-22 | Purchase | 3,898 | $1.15 | $4,482.70 | 24% 16.09K to 19.99K | |
| 16-May-22 10:00 PM View: | Wanstall Rick CFO and Treasurer | Oncorus, Inc. (ONCR) | 12-May-22 | Private Purchase | 14,094 | $1.08 | $15,221.50 | 705% 2.0K to 16.09K | |
| 22-Nov-21 6:30 AM View: | Ashburn Theodore President and CEO Director | Oncorus, Inc. (ONCR) | 19-Nov-21 | Option Exercise | 32,500 | $1.81 | $58,825.00 | 49% 66.85K to 99.35K | |
| 17-Nov-21 4:05 PM View: | Harbin Stephen COO and Chief of Staff | Oncorus, Inc. (ONCR) | 16-Nov-21 | Market Purchase | 15,000 | $5.80 | $86,955.00 | 100% 0 to 15.0K | < 1% |
| 17-Nov-21 4:05 PM View: | Harbin Stephen COO and Chief of Staff | Oncorus, Inc. (ONCR) | 16-Nov-21 | Market Purchase | 15,000 | $5.78 | $86,700.00 | 100% 15.0K to 30.0K | 1% |
| 25-Oct-21 5:06 PM View: | Ashburn Theodore President and CEO Director | Oncorus, Inc. (ONCR) | 22-Oct-21 | Option Exercise | 43,707 | $1.81 | $79,109.70 | 189% 23.14K to 66.85K | |
| 03-Jun-21 5:15 PM View: | Queva Christophe CSO and SVP, Research | Oncorus, Inc. (ONCR) | 02-Jun-21 | Market Sale (Planned) | 10,656 | $16.66 | $177,529.00 | (18%) 58.28K to 47.63K | (< 1%) |
| 03-Jun-21 5:15 PM View: | Queva Christophe CSO and SVP, Research | Oncorus, Inc. (ONCR) | 01-Jun-21 | Market Sale (Planned) | 12,899 | $16.69 | $215,284.00 | (18%) 71.18K to 58.28K | (< 1%) |
| 26-May-21 4:31 PM View: | Queva Christophe CSO and SVP, Research | Oncorus, Inc. (ONCR) | 24-May-21 | Option Exercise | 35,561 | $1.81 | $64,365.40 | 100% 35.62K to 71.18K | |
| 04-May-21 5:33 PM View: | Queva Christophe CSO and SVP, Research | Oncorus, Inc. (ONCR) | 30-Apr-21 | Market Sale (Planned) | 23,555 | $15.97 | $376,123.00 | (40%) 59.17K to 35.62K | (< 1%) |
| 28-Apr-21 7:32 PM View: | Queva Christophe CSO and SVP, Research | Oncorus, Inc. (ONCR) | 28-Apr-21 | Market Sale (Planned) | 17,990 | $15.22 | $273,808.00 | (23%) 77.17K to 59.17K | 2% |
| 28-Apr-21 7:32 PM View: | Queva Christophe CSO and SVP, Research | Oncorus, Inc. (ONCR) | 27-Apr-21 | Market Sale (Planned) | 211 | $15.00 | $3,165.00 | (< 1%) 77.38K to 77.17K | < 1% |
| 28-Apr-21 7:32 PM View: | Queva Christophe CSO and SVP, Research | Oncorus, Inc. (ONCR) | 26-Apr-21 | Market Sale (Planned) | 54 | $15.00 | $810.00 | (< 1%) 77.43K to 77.38K | < 1% |
| 09-Apr-21 4:30 PM View: | Ashburn Theodore President and CEO Director | Oncorus, Inc. (ONCR) | 07-Apr-21 | Option Exercise | 4,699 | $5.32 | $24,998.70 | 25% 18.45K to 23.14K | |
| 08-Apr-21 4:57 PM View: | Queva Christophe CSO and SVP, Research | Oncorus, Inc. (ONCR) | 06-Apr-21 | Market Sale (Planned) | 5,300 | $15.01 | $79,553.00 | (6%) 82.73K to 77.43K | (11%) |
| 18-Feb-21 6:44 PM View: | Flynn James E Director 10% Owner | Oncorus, Inc. (ONCR) | 17-Feb-21 | Market Purchase | 300,000 | $19.00 | $5,700,000.00 | 11% 2.85M to 3.15M | (11%) |
| 09-Apr-21 4:30 PM View: | Ashburn Theodore President and CEO Director | Oncorus, Inc. (ONCR) | 31-Dec-20 | Option Exercise | 1,900 | $1.81 | $3,439.00 | 11% 16.55K to 18.45K | |
| 08-Oct-20 6:26 PM View: | Ubs Oncology Impact Fund L.P. 10% Owner | Oncorus, Inc. (ONCR) | 06-Oct-20 | Purchase | 151,224 | $15.00 | $2,268,360.00 | 7% 2.23M to 2.38M | |
| 08-Oct-20 6:27 PM View: | Evnin Luke Director 10% Owner | Oncorus, Inc. (ONCR) | 06-Oct-20 | Purchase | 151,225 | $15.00 | $2,268,380.00 | 2% 6.32M to 6.48M | |
| 08-Oct-20 6:31 PM View: | Mpm Bioventures 2014, L.P. 10% Owner | Oncorus, Inc. (ONCR) | 06-Oct-20 | Conversion | 2,559,850 | -- | -- | 55% 4.69M to 7.25M | |
| 08-Oct-20 6:35 PM View: | Mpm Sunstates Fund, L.P. 10% Owner | Oncorus, Inc. (ONCR) | 06-Oct-20 | Purchase Duplicate | 173,776 | $15.00 | $2,606,640.00 | 2% 7.25M to 7.42M | |
| 08-Oct-20 5:31 PM View: | Flynn James E Director 10% Owner | Oncorus, Inc. (ONCR) | 06-Oct-20 | Conversion | 1,848,970 | -- | -- | 100% 0 to 1.85M | |
| 08-Oct-20 6:28 PM View: | Gadicke Ansbert 10% Owner | Oncorus, Inc. (ONCR) | 06-Oct-20 | Conversion | 4,785,660 | -- | -- | 102% 4.69M to 9.48M | |
| 08-Oct-20 6:31 PM View: | Mpm Bioventures 2014, L.P. 10% Owner | Oncorus, Inc. (ONCR) | 06-Oct-20 | Purchase | 173,776 | $15.00 | $2,606,640.00 | 2% 7.25M to 7.42M | |
| 08-Oct-20 6:33 PM View: | Nam Spencer Director | Oncorus, Inc. (ONCR) | 06-Oct-20 | Conversion | 1,924 | -- | -- | 100% 0 to 1.92K | |
| 08-Oct-20 6:26 PM View: | Ubs Oncology Impact Fund L.P. 10% Owner | Oncorus, Inc. (ONCR) | 06-Oct-20 | Conversion | 2,225,800 | -- | -- | 100% 0 to 2.23M | |
| 08-Oct-20 5:31 PM View: | Flynn James E Director 10% Owner | Oncorus, Inc. (ONCR) | 06-Oct-20 | Purchase | 1,000,000 | $15.00 | $15,000,000.00 | 54% 1.85M to 2.85M | |
| 08-Oct-20 6:27 PM View: | Evnin Luke Director 10% Owner | Oncorus, Inc. (ONCR) | 06-Oct-20 | Conversion | 2,225,800 | -- | -- | 54% 4.1M to 6.32M | |
| 08-Oct-20 6:28 PM View: | Gadicke Ansbert 10% Owner | Oncorus, Inc. (ONCR) | 06-Oct-20 | Purchase | 325,000 | $15.00 | $4,875,000.00 | 3% 9.48M to 9.8M | |
| 08-Oct-20 6:35 PM View: | Mpm Sunstates Fund, L.P. 10% Owner | Oncorus, Inc. (ONCR) | 06-Oct-20 | Conversion Duplicate | 2,559,850 | -- | -- | 55% 4.69M to 7.25M |
